A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma

• Status: Not yet recruiting
• Trial end date: 2025-12-05

Summary

The purpose of this study is to see if taking ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is reasonable, safe and can stabilize or increase weight along with quality of life in pancreatic cancer patients.

• Phase: Early Phase 1

Details

• Lead Sponsor: Andrew Hendifar, MD
• Treatments: Ketorolac; Ketorolac Tromethamine